ClinConnect ClinConnect Logo
Search / Trial NCT05000528

Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Aug 3, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help people with chronic insomnia, which affects about 20 to 30% of the population. The researchers want to find out if "therapeutic education," which involves group workshops, is more effective than traditional one-on-one consultations for treating sleep problems. In these workshops, participants will learn about healthy sleep habits, how sleep changes as we age, and the potential risks of using sleeping pills. They will also have the chance to share experiences with others facing similar challenges, which can make the process of managing insomnia easier and quicker.

To participate in this study, individuals must be aged 65 to 74, be able to read and understand French, and meet certain criteria for chronic insomnia. This includes having specific symptoms as measured by a sleep questionnaire. However, those with cognitive impairments, certain medical conditions, or substance abuse issues are not eligible. If you join the trial, you can expect to attend group sessions that focus on learning and improving your sleep without relying heavily on medication. This could be a good opportunity to gain knowledge and support while addressing your sleep concerns.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The patient must have given their free and informed consent
  • The patient must be a member or beneficiary of a health insurance plan
  • Patient must understand and read French
  • Patient with ICSD-3 diagnostic criteria for chronic insomnia: ISI score \> 14/28.
  • Exclusion Criteria:
  • Patient with cognitive impairment as assessed by the investigator
  • Patient with shift work
  • Patients scoring \> 10/24 on the Epworth sleepiness scale
  • Patient suffering from medical or psychiatric illnesses which may, in the opinion of the investigator, compromise the subject's state of health or ability to participate in the study.
  • Patient with chronic alcohol consumption or drug abuse
  • Patient unable to express consent.
  • Pregnant, parturient or breastfeeding patient.
  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

About Centre Hospitalier Universitaire De Nīmes

The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.

Locations

Nimes, , France

Patients applied

0 patients applied

Trial Officials

Beatriz Abril

Principal Investigator

Centre Hospitalier Universitaire de Nīmes

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials